SalvaRx Group plc announced unaudited consolidated earnings results for the six months ended June 30, 2018. For the six months, the company reported operating loss of £1,985,000 against £1,331,000 for the same period a year ago. Loss before tax was £2,145,000 against £1,403,000 for the same period a year ago. Net loss and comprehensive loss was £1,996,000 against £1,388,000 for the same period a year ago. Net loss and comprehensive loss attributable to owners of the company was £1,894,000 against £1,091,000 for the same period a year ago. Basic and diluted loss per share was 0.05 pence against 0.03 pence for the same period a year ago. Net cash outflow from operating activities was £1,056,000 against £940,000 for the same period a year ago.